Infographic: FDA gains authority to prescribe less, but opioid prescriptions decreasing

By Maggie Lynch

- Last updated on GMT

(Image: Getty/	SARINYAPINNGAM)
(Image: Getty/ SARINYAPINNGAM)

Related tags Opioid Opioid epidemic overdose

President Donald Trump signed the SUPPORT Act granting the FDA additional authority to combat the opioid epidemic, but a pain management CRO argues that opioid addiction isn't the only crisis.

After the SUPPORT Act was signed into legislation, Lynn Webster, VP of Scientific Affairs and Neuroscience at PRA Health Sciences, a clinical contract research organization (CRO), stated the new legislation has its shortcomings. 

One of the shortcomings, according to Webster, is that despite a continual decline in opioid prescription over the past several years, the legislation grants the FDA the ability to reduce the overall number of opioids in circulation. 

"There is a disconnect between the ​amount of prescribed opioids and the number of drug overdoses,"​ said Webster who believes the root cause of the drug crisis is complex and was not fully addressed by the legislation. 

Related news

Show more

Related products

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

The Complete Guide to eRegulatory and eSource

The Complete Guide to eRegulatory and eSource

Content provided by Florence Healthcare | 01-Apr-2023 | Insight Guide

Shifting to eRegulatory and eSource workflows is a requirement for clinical trial sites to continue to scale and grow their studies. This guide is designed...

Follow us

Products

View more

Webinars